Clinical trials: Cat Hypersensitivity
Cat Allergy, Cat Hypersensitivity
Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy
This trial will test whether a novel therapeutic approach, cat immunotherapy combined with an investigational new drug called MEDI9929/AMG 157 (an anti-TSLP [thymic stromal lymphopoietin] antibody being co-developed by Amgen and…
- Trial name
- NCT02237196
- Testing
- AMG 157, Cat Immunotherapy
- Where
- 9 sites in United States
- Volunteers
- 121 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)